Cargando…

Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti

Background: Access to antiretroviral therapy (ART) has expanded in Haiti because of the adoption of Option B+ and the revision of treatment guidelines. Retention in care and treatment varies greatly and few studies have examined retention rates, particularly among women enrolled in Option B+. Object...

Descripción completa

Detalles Bibliográficos
Autores principales: Domercant, Jean Wysler, Puttkammer, Nancy, Young, Paul, Yuhas, Krista, François, Kesner, Grand’Pierre, Reynold, Lowrance, David, Adler, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496080/
https://www.ncbi.nlm.nih.gov/pubmed/28640661
http://dx.doi.org/10.1080/16549716.2017.1330915
_version_ 1783247897213534208
author Domercant, Jean Wysler
Puttkammer, Nancy
Young, Paul
Yuhas, Krista
François, Kesner
Grand’Pierre, Reynold
Lowrance, David
Adler, Michelle
author_facet Domercant, Jean Wysler
Puttkammer, Nancy
Young, Paul
Yuhas, Krista
François, Kesner
Grand’Pierre, Reynold
Lowrance, David
Adler, Michelle
author_sort Domercant, Jean Wysler
collection PubMed
description Background: Access to antiretroviral therapy (ART) has expanded in Haiti because of the adoption of Option B+ and the revision of treatment guidelines. Retention in care and treatment varies greatly and few studies have examined retention rates, particularly among women enrolled in Option B+. Objective: To assess attrition among pregnant and non-pregnant patients initiating ART following adoption of Option B+ in Haiti. Methods: Longitudinal data of adult patients initiated on ART from October 2012 through August 2014 at 73 health facilities across Haiti were analyzed using a survival analysis framework to determine levels of attrition. The Kaplan–Meier method and Cox proportional hazards regression were used to examine risk factors associated with attrition. Results: Among 17,059 patients who initiated ART, 7627 (44.7%) were non-pregnant women, 5899 (34.6%) were men, and 3533 (20.7%) were Option B+ clients. Attrition from the ART program was 36.7% at 12 months (95% CI: 35.9–37.5%). Option B+ patients had the highest level of attrition at 50.4% at 12 months (95% CI: 48.6–52.3%). While early HIV disease stage at ART initiation was protective among non-pregnant women and men, it was a strong risk factor among Option B+ clients. In adjusted analyses, key protective factors were older age (p < 0.0001), living near the health facility (p = 0.04), having another known HIV-positive household member (p < 0.0001), having greater body mass index (BMI) (p < 0.0001), pre-ART counseling (p < 0.0001), and Cotrimoxazole prophylaxis during baseline (p < 0.01). Higher attrition was associated with rapidly starting ART after enrollment (p < 0.0001), anemia (p < 0.0001), and regimen tenofovir+lamivudine+nevirapine (TDF+3TC+NVP) (p < 0.001). Conclusions: ART attrition in Haiti is high among adults, especially among Option B+ patients. Identifying newly initiated patients most at risk for attrition and providing appropriate interventions could help reduce ART attrition.
format Online
Article
Text
id pubmed-5496080
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-54960802017-07-11 Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti Domercant, Jean Wysler Puttkammer, Nancy Young, Paul Yuhas, Krista François, Kesner Grand’Pierre, Reynold Lowrance, David Adler, Michelle Glob Health Action Original Article Background: Access to antiretroviral therapy (ART) has expanded in Haiti because of the adoption of Option B+ and the revision of treatment guidelines. Retention in care and treatment varies greatly and few studies have examined retention rates, particularly among women enrolled in Option B+. Objective: To assess attrition among pregnant and non-pregnant patients initiating ART following adoption of Option B+ in Haiti. Methods: Longitudinal data of adult patients initiated on ART from October 2012 through August 2014 at 73 health facilities across Haiti were analyzed using a survival analysis framework to determine levels of attrition. The Kaplan–Meier method and Cox proportional hazards regression were used to examine risk factors associated with attrition. Results: Among 17,059 patients who initiated ART, 7627 (44.7%) were non-pregnant women, 5899 (34.6%) were men, and 3533 (20.7%) were Option B+ clients. Attrition from the ART program was 36.7% at 12 months (95% CI: 35.9–37.5%). Option B+ patients had the highest level of attrition at 50.4% at 12 months (95% CI: 48.6–52.3%). While early HIV disease stage at ART initiation was protective among non-pregnant women and men, it was a strong risk factor among Option B+ clients. In adjusted analyses, key protective factors were older age (p < 0.0001), living near the health facility (p = 0.04), having another known HIV-positive household member (p < 0.0001), having greater body mass index (BMI) (p < 0.0001), pre-ART counseling (p < 0.0001), and Cotrimoxazole prophylaxis during baseline (p < 0.01). Higher attrition was associated with rapidly starting ART after enrollment (p < 0.0001), anemia (p < 0.0001), and regimen tenofovir+lamivudine+nevirapine (TDF+3TC+NVP) (p < 0.001). Conclusions: ART attrition in Haiti is high among adults, especially among Option B+ patients. Identifying newly initiated patients most at risk for attrition and providing appropriate interventions could help reduce ART attrition. Taylor & Francis 2017-06-22 /pmc/articles/PMC5496080/ /pubmed/28640661 http://dx.doi.org/10.1080/16549716.2017.1330915 Text en © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Domercant, Jean Wysler
Puttkammer, Nancy
Young, Paul
Yuhas, Krista
François, Kesner
Grand’Pierre, Reynold
Lowrance, David
Adler, Michelle
Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti
title Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti
title_full Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti
title_fullStr Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti
title_full_unstemmed Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti
title_short Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti
title_sort attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of option b+ in haiti
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496080/
https://www.ncbi.nlm.nih.gov/pubmed/28640661
http://dx.doi.org/10.1080/16549716.2017.1330915
work_keys_str_mv AT domercantjeanwysler attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti
AT puttkammernancy attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti
AT youngpaul attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti
AT yuhaskrista attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti
AT francoiskesner attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti
AT grandpierrereynold attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti
AT lowrancedavid attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti
AT adlermichelle attritionfromantiretroviraltreatmentservicesamongpregnantandnonpregnantpatientsfollowingadoptionofoptionbinhaiti